These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36565724)

  • 1. Fungal infections and the fungal microbiome in hepatobiliary disorders.
    Hartmann P; Schnabl B
    J Hepatol; 2023 Apr; 78(4):836-851. PubMed ID: 36565724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses.
    Fidel PL; Thompson ZA; Lilly EA; Granada C; Treas K; Dubois KR; Cook L; Hashmi SB; Lisko DJ; Mukherjee C; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Beall CJ
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
    Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
    Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut mycobiome: A "black box" of gut microbiome-host interactions.
    Zhao X; Hu X; Han J; Yin R; Zhang S; Liu H
    WIREs Mech Dis; 2023; 15(5):e1611. PubMed ID: 37157158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fecal mycobiome in non-alcoholic fatty liver disease.
    Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
    J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.
    Li J; Chen D; Yu B; He J; Zheng P; Mao X; Yu J; Luo J; Tian G; Huang Z; Luo Y
    Microb Ecol; 2018 May; 75(4):821-829. PubMed ID: 29110065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi.
    Auchtung TA; Fofanova TY; Stewart CJ; Nash AK; Wong MC; Gesell JR; Auchtung JM; Ajami NJ; Petrosino JF
    mSphere; 2018; 3(2):. PubMed ID: 29600282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
    Chu H; Duan Y; Lang S; Jiang L; Wang Y; Llorente C; Liu J; Mogavero S; Bosques-Padilla F; Abraldes JG; Vargas V; Tu XM; Yang L; Hou X; Hube B; Stärkel P; Schnabl B
    J Hepatol; 2020 Mar; 72(3):391-400. PubMed ID: 31606552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut mycobiome and metabolic diseases: The known, the unknown, and the future.
    Wang L; Zhang K; Zeng Y; Luo Y; Peng J; Zhang J; Kuang T; Fan G
    Pharmacol Res; 2023 Jul; 193():106807. PubMed ID: 37244385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
    Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut mycobiota changes in liver diseases: A systematic review.
    Perlin CM; Longo L; Keingeski MB; Picon RV; Álvares-da-Silva MR
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37463798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.
    Zhang L; Chen C; Chai D; Li C; Qiu Z; Kuang T; Liu L; Deng W; Wang W
    J Transl Med; 2023 Feb; 21(1):126. PubMed ID: 36793057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?
    Musumeci S; Coen M; Leidi A; Schrenzel J
    Clin Microbiol Infect; 2022 Jan; 28(1):58-63. PubMed ID: 34363944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastmilk and NICU surfaces are potential sources of fungi for infant mycobiomes.
    Heisel T; Nyaribo L; Sadowsky MJ; Gale CA
    Fungal Genet Biol; 2019 Jul; 128():29-35. PubMed ID: 30905830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
    PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.
    Lang S; Duan Y; Liu J; Torralba MG; Kuelbs C; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Lucey MR; Louvet A; Mathurin P; Garcia-Tsao G; Ho SB; Tu XM; Bataller R; Stärkel P; Fouts DE; Schnabl B
    Hepatology; 2020 Feb; 71(2):522-538. PubMed ID: 31228214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium.
    Panpetch W; Somboonna N; Palasuk M; Hiengrach P; Finkelman M; Tumwasorn S; Leelahavanichkul A
    PLoS One; 2019; 14(1):e0210798. PubMed ID: 30645630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.